These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14550820)

  • 1. Mycophenolate mofetil significantly reduces leukocyte graft infiltration after heterotopic cardiac transplantation in a rat model: comparative study with cyclosporine and FK 506.
    Richter MH; Zahn S; Kraus M; Mohr FW; Olbrich HG
    J Heart Lung Transplant; 2003 Oct; 22(10):1107-16. PubMed ID: 14550820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy.
    Richter M; Zahn S; Richter H; Mohr FW; Olbrich HG
    J Heart Lung Transplant; 2004 Dec; 23(12):1405-13. PubMed ID: 15607671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab induction in deceased donor kidney transplantation.
    Huang E; Cho YW; Hayashi R; Bunnapradist S
    Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?
    Meiser BM; Groetzner J; Kaczmarek I; Landwehr P; Müller M; Jung S; Uberfuhr P; Fraunberger P; Stempfle HU; Weis M; Reichart B
    Transplantation; 2004 Aug; 78(4):591-8. PubMed ID: 15446320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
    Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
    Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats.
    Harrison PC; Madwed JB
    J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
    Noris M; Azzollini N; Pezzotta A; Mister M; Benigni A; Marchetti G; Gagliardini E; Perico N; Remuzzi G
    J Am Soc Nephrol; 2001 Sep; 12(9):1937-1946. PubMed ID: 11518788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.
    Bunnapradist S; Takemoto SK
    Transplant Proc; 2003 Nov; 35(7):2407-8. PubMed ID: 14611971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporine A and methotrexate on CD18 expression in recipients of rat cardiac allografts.
    Ciesielski CJ; Mei J; Piccinini LA
    Transpl Immunol; 1998 Jun; 6(2):122-33. PubMed ID: 9777701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.
    Bogossian H; Frommeyer G; Ninios I; Bandorski D; Seyfarth M; Matzaroglou C; Lemke B; Eckardt L; Zarse M; Kafchitsas K
    Cardiovasc Ther; 2016 Aug; 34(4):183-90. PubMed ID: 26924260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion.
    Gibson SW; Valente JF; Alexander JW; Custer DA; Babcock GF; Ogle CK
    J Heart Lung Transplant; 1999 Mar; 18(3):185-9. PubMed ID: 10328142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.